Labshake search
Citations for Invivogen :
101 - 150 of 198 citations for 7 Hydroxy 4 methylcoumarin 3 acetic acid succinimidyl ester since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2021Quote: ... was mixed with an Al (OH)3 adjuvant (Alhydrogel®, InvivoGen, France) and used as a candidate vaccine against SARS-CoV-2 ...
-
bioRxiv - Immunology 2020Quote: ... the medium was supplemented with 3 μM puromycin (InvivoGen, #ant-pr-1). Then ...
-
bioRxiv - Microbiology 2020Quote: ... then incubated with 1 µM okadaic acid 30 min before transfer onto transgenic IL-1R reporter cells (Invivogen). After 18 h ...
-
bioRxiv - Molecular Biology 2021Quote: ... HuH-7 Flp-In cell line stocks and their derivatives were cultured in medium containing zeocin (100 µg/ml, InvivoGen, Cat#: ant-zn-05) or hygromycin B Gold (200 µg/ml ...
-
bioRxiv - Cancer Biology 2021Quote: ... Cells were treated with 3 μg/ml plasmocin (Invivogen, San Diego, CA, USA) to prevent mycoplasma contamination ...
-
bioRxiv - Genetics 2019Quote: ... For stable sgRNA and shRNA expression 3 days puromycin (2 μg/ml, Invivogen) selection was applied.
-
bioRxiv - Cancer Biology 2020Quote: ... Transduced cells were selected for 3 weeks using puromycin (5 μg/mL,-InvivoGen).
-
bioRxiv - Immunology 2022Quote: ... and with 3 μg/ml TLR7 agonist imiquimod (InvivoGen, San Diego, CA, USA) for 3 days ...
-
bioRxiv - Immunology 2023Quote: ... The Class B CpG ODN2006 (ODN 7909, PF_3512676, sequence: 5’-tcgtcgttttgtcgttttgtcgtt-3’, Invivogen) was diluted in sterile endotoxin-free water ...
-
Increased dosage of wild-type KRAS protein drives KRAS-mutant lung tumorigenesis and drug resistancebioRxiv - Cancer Biology 2024Quote: ... Infected cells were selected using puromycin for 3 days (2 µg/ml, InvivoGen) or hygromycin B for 7 days (500 µg/ml ...
-
bioRxiv - Immunology 2019Quote: ... Deletion of the gene encoding vinculin was induced by intraperitoneal injection of 250 μg of polyinosinic–polycytidylic acid (Poly I:C; InvivoGen), three doses ...
-
bioRxiv - Cell Biology 2023Quote: ... mice were intraperitoneally injected once every other day for five total injections with 15 mg/kg high molecular weight polyinosinic-polycytidylic acid (polyI:C) (InvivoGen). In all experiments ...
-
bioRxiv - Immunology 2023Quote: ... was diluted in sterile endotoxin-free water. TLR3 agonist polyinosinic-polycytidylic acid - Poly(I:C) and TLR4 agonist LPS (Lipopolysaccharide from E. coli O55:B5) (Invivogen) were diluted in sterile endotoxin-free physiological water (NaCl 0.9%) ...
-
bioRxiv - Genetics 2023Quote: ... mice were intraperitoneally injected once every other day for five total injections with 15 mg/kg high molecular weight polyinosinic-polycytidylic acid (polyI:C) (InvivoGen). Mice used for experiments were at least 10-weeks following polyI:C administration ...
-
bioRxiv - Cell Biology 2021Quote: ... infected cells were selected with medium containing 3 μg/ml puromycin medium (Invivogen, CA) for 4 days and resulting heterogenous pools were used for functional assays ...
-
bioRxiv - Immunology 2021Quote: ... and incubated for 3 hours in the presence of LPS (10 ng/ml, Invivogen). Primary monocytes were then treated for 1 h 30 with nigericin (5 μM ...
-
bioRxiv - Biophysics 2023Quote: ... MEFs stably expressing Skylan-NS–LC3B were selected with 3 µg/mL puromycin (Invivogen), seeded on a glass slide coated with 0.3 mg/ml collagen (Nitta Gelatin ...
-
bioRxiv - Biophysics 2023Quote: ... Cell culture media was supplemented with 3 µg/ml puromycin (InvivoGen, San Diego, USA). As a control ...
-
bioRxiv - Immunology 2020Quote: Neutrophils isolated from 4 healthy volunteers were plated at 50,000 cells per well and stimulated in duplicate with the following ligands for 1 hour: lipotechoic acid (LTA) 100ng/mL (Invivogen), LPS (Sigma ...
-
bioRxiv - Immunology 2020Quote: ... The immunization mixture contained 13 μg of SARS-CoV-2-S-I53-50NPs (equal to 10 μg of SARS-CoV-2-S) adjuvanted with 50 μg of polyinosinic-polycytidylic acid (Poly-IC; Invivogen). Blood was collected at weeks-1,2 ...
-
bioRxiv - Immunology 2023Quote: ... frozen cells were washed twice in complete medium (RPMI with GlutaMAX, 10% FBS, 1 × nonessential amino acids, 1 × sodium pyruvate, 1 × penicillin/streptomycin, 1 × Normocin from InvivoGen), and 2 × 107 cells per ml were suspended in complete RPMI ...
-
bioRxiv - Immunology 2024Quote: ... and BA.4/5 variants harboring GFP and luciferase reporter genes was performed as previously described for the WT PSV.43 Plasmids carrying the full-length SARS-CoV-2 spike protein from each variant containing a C-terminal 19 amino acid deletion to remove the ER retention signal were used for pseudotyping (Invivogen). Viral titers (TU/mL ...
-
bioRxiv - Systems Biology 2023Quote: ... TLR4 agonist at 4 ng/mL (LPS-B5, Invivogen, San Diego, CA), BTC at 40 ng/mL (human recombinant Betacellulin protein ...
-
bioRxiv - Immunology 2023Quote: ... cells were transferred to selective medium containing 4 µg/mL Blasticidin (Invivogen) (MC38-B2m-/- transduced with Her2/neu ...
-
bioRxiv - Cancer Biology 2021Quote: ... 6-8 weeks old CM knock-in mice were injected intraperitoneally with polyinosinic–polycytidylic acid [poly (I:C)] (InvivoGen, tlrl-picw-250) at 14 mg/kg/dose every other day for a total of 7 doses ...
-
bioRxiv - Microbiology 2019Quote: ... Transduced cells were then selected with both 3 μg/mL puromycin (InvivoGen #ant-pr-1) and 10 μg/mL blasticidin (InvivoGen #ant-bl-1 ...
-
bioRxiv - Molecular Biology 2020Quote: ... Disease was induced between 6 and 10 weeks of age using 3 mg curdlan (InvivoGen) administered by intraperitoneal injection ...
-
bioRxiv - Immunology 2020Quote: ... Cells were treated with 12.5 or 25 μg/mL 2’-3’cGAMP (Invivogen tlrl-nacga23) for 2 hr as indicated ...
-
bioRxiv - Immunology 2023Quote: ... The Class C CpG ODN_2395 sequence (5’-TCGTCGTTTTCGGCGCGCGCCG-3’) was obtained from Invivogen (#tlrl-2395). We used the crystal structure of mouse TLR9 extracellular domain (TLR9 ECD ...
-
bioRxiv - Cancer Biology 2024Quote: ... or 10 mg/kg anti-CTLA-4 (clone 9D9, cat. mctla4-mab10, InvivoGen). Antibodies were administered twice weekly for a maximum of four weeks.
-
bioRxiv - Immunology 2023Quote: ... and absorbance levels detected at 655 nm after 3 h incubation with QUANTI-Blue Solution (Invivogen). The absorbances of RAW-Blue assay were normalized to absorbance intensity at the highest and lowest dilutions ...
-
bioRxiv - Cell Biology 2023Quote: ... cells were selected in culture medium supplemented with 3 µg/ml puromycin (Invivogen, ant-pr-1), and selection was completed for 48 h before cells were harvested ...
-
bioRxiv - Biochemistry 2024Quote: ... HeLa cells were then cultured under selection with 3 μg/mL puromycin (InvivoGen, ant-pr-1) for 48hr and then expanded before storing stocks in liquid nitrogen.
-
bioRxiv - Immunology 2020Quote: ... the cells were primed for 4 h with 500 ng/mL ultrapure LPS (InvivoGen). The supernatant was discharged and macrophages were infected with trypomastigote forms of T ...
-
bioRxiv - Immunology 2023Quote: Five zebrafish housed in 400-mL beakers containing 200mL sterile tank water were immersed in high molecular weight polyinosine-polycytidylic acid (HMW poly I:C, InvivoGen Cat.# tlrl-pic-5) (50µg/mL final concentration in 200mL tank water ...
-
bioRxiv - Immunology 2024Quote: ... mice were intradermally injected with 50 μg of neoantigen or control peptide and/or 100 μg high molecular weight VacciGrade polyinosinic-polycytidylic acid (poly(I:C) (Invivogen Cat. No. vac-pic)) ...
-
bioRxiv - Microbiology 2019Quote: ... Transduced cells were selected with 3 μg/mL puromycin (InvivoGen, San Diego, CA, catalogue #ant-pr-1), 10 μg/mL blasticidin (InvivoGen ...
-
bioRxiv - Immunology 2021Quote: ... Labeled cells (0.5x106 cells/mL) were cultured for 2-3 days with 5 μg/mL R848 (InvivoGen), 50 U/mL IL-2 (Peprotech) ...
-
bioRxiv - Genomics 2022Quote: ... and incubated in fresh 3 mM EDTA in ice cold PBS with 1% (v/v) primocin (InvivoGen) for 40 min at 4°C ...
-
bioRxiv - Microbiology 2023Quote: ... Transduced cells were selected with 3 μg/mL puromycin (InvivoGen, San Diego, CA, catalogue #ant-pr-1) for 3 days ...
-
bioRxiv - Microbiology 2024Quote: ... providing an additional metric for assessing cell health post-drug treatment for both 2’-3’cGAMP (Invivogen) and Sulfasalazine (Cayman Chemical).
-
bioRxiv - Biochemistry 2023Quote: ... and 50 µL of the working solution of the QUANTI1Luc 4 Lucia/Gaussia reagent (Invivogen) was added ...
-
bioRxiv - Microbiology 2022Quote: ... 1% (v/v) nonessential amino acid (Multicell Wisent Inc., St-Bruno, QC, Canada) and 5μg/mL of Plasmocin® (Invivogen, San Diego, CA, USA), to prevent mycoplasma contamination ...
-
bioRxiv - Cancer Biology 2022Quote: ... The infected cultures were selected by sorting of RFP+ cells 3 days after transduction and expanded in supplemented media with puromycin (2.5µg/ml; InvivoGen) and blasticidin (1µg/ml ...
-
bioRxiv - Developmental Biology 2023Quote: ... Clones were selected with 3 μg/mL (and maintained with 1μg/mL) of Puromycin (Invivogen, #ant-pr-5b).
-
bioRxiv - Cell Biology 2023Quote: ... co-transfected cells were selected in culture medium supplemented with 3 μg/ml puromycin (Invivogen, ant-pr-1), until selection was complete after about 48 h ...
-
bioRxiv - Immunology 2022Quote: ... N = 3) were immunized with a mixture of 50 μg each of H1ssF and H10ssF formulated with AddaVax (Invivogen) in 1 ml via intramuscular route at weeks 0 ...
-
bioRxiv - Neuroscience 2021Quote: ... with half media changes every 2-3 days with Neurobasal (ThermoFisher #21103049 supplemented with Primocin (InvivoGen #ant-pm-1), B-27 (ThermoFisher #17504044 ...
-
bioRxiv - Immunology 2021Quote: ... were transduced 3 times with lentivirus containing supernatant and selected with 1 μg/ml Puromycin (Invivogen, San Diego, USA). Surviving cells were expanded and referred to as HEK293 luciferase reporter cells.
-
bioRxiv - Microbiology 2020Quote: ... DNA ratio of 3:1 according to manufacturer’s instructions or with Poly(I:C) (LMW)/LyoVec™ (tlrl-picwlv, InvivoGen). The treatment was administered as indicated ...